MultiPlan Corporation reported Q1 2022 revenues of $298.0 million, a 16.9% increase over Q1 2021. Net income was $44.0 million, and Adjusted EBITDA was $225.4 million. The company processed approximately $31.7 billion in claim charges, identifying potential medical cost savings of approximately $5.6 billion.
Revenues of $298.0 million for Q1 2022, an increase of 16.9% over Q1 2021 revenues of $254.9 million.
Net income of $44.0 million for Q1 2022, a decrease of 4.1% from Q1 2021 net income of $45.9 million.
Adjusted EBITDA of $225.4 million for Q1 2022, an increase of 17.9% over Q1 2021 Adjusted EBITDA of $191.1 million.
Free Cash Flow of $170.5 million for Q1 2022, compared to $152.8 million for Q1 2021.
The Company is maintaining its Full Year 2022 guidance. The Company anticipates Q2 2022 revenues between $285 million and $295 million and Adjusted EBITDA between $205 million and $215 million.
Analyze how earnings announcements historically affect stock price performance